Cannabis Wheaton Income Corp. announced that it has entered into an exclusive data licensing agreement with a prominent Canadian cannabis testing, analysis and rating company. Pursuant to the Agreement, the Licensor will grant the Company an exclusive license to all current and future proprietary cannabis testing, review and ranking data for a term of two years. The Licensor has tested, reviewed and ranked over 2,000 Canadian cannabis samples to date, including some of the most popular strains sold by licensed producers under the ACMPR, with the objective of analyzing the cannabinoid content, terpene profile and aesthetic characteristics of such samples and ranking over 6,000 cannabis strain samples over the next two years. The Data will consist of various objective data points including, strain information, cannabinoid content (THC, CBD, CBG, CBN, CBG), terpene content, as well as any additional data derived from associated laboratory tests such as microbial, chemical and pesticide content. The Data will provide the Company with valuable insights from cannabis obtained by authorized patients across Canada. Using the Licensor's proprietary algorithms, the resulting Data offers sophisticated analysis into the quality, stability, and value of various cannabis strains, lots and batches. The Company believes that the Data is an important source of information and will provide the Company and its various partners and distribution channels with the necessary methodology to rank and rate cannabis available for purchase across Canada at any given time. This will give the Company the ability to provide purchasers with an objective basis upon which to compare and price available product supply and make purchasing decisions on an informed basis.